Search Page

1

Cite

Share

Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship.

Dibra D, Mishra L, Li S. Dibra D, et al. Biochim Biophys Acta. 2014 Aug;1846(1):152-60. doi: 10.1016/j.bbcan.2014.05.001. Epub 2014 May 9. Biochim Biophys Acta. 2014. PMID: 24821201 Free PMC article. Review.

Cite

Share

2

Cite

Share

Intricacies for posttranslational tumor-targeted cytokine gene therapy.

Cutrera J, Dibra D, Satelli A, Xia X, Li S. Cutrera J, et al. Among authors: dibra d. Mediators Inflamm. 2013;2013:378971. doi: 10.1155/2013/378971. Epub 2013 Nov 27. Mediators Inflamm. 2013. PMID: 24369443 Free PMC article.

Cite

Share

3

Cite

Share

A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53.

Dibra D, Xia X, Gagea M, Lozano G, Li S. Dibra D, et al. PLoS One. 2018 Mar 1;13(3):e0193485. doi: 10.1371/journal.pone.0193485. eCollection 2018. PLoS One. 2018. PMID: 29494633 Free PMC article.

Cite

Share

4

Cite

Share

Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo.

Dibra D, Mitra A, Newman M, Xia X, Cutrera JJ, Gagea M, Kleinerman ES, Lozano G, Li S. Dibra D, et al. Clin Cancer Res. 2016 Aug 1;22(15):3876-83. doi: 10.1158/1078-0432.CCR-15-2052. Epub 2016 Mar 15. Clin Cancer Res. 2016. PMID: 26979394 Free PMC article.

Cite

Share

5

Cite

Share

Universal marker and detection tool for human sarcoma circulating tumor cells.

Satelli A, Mitra A, Cutrera JJ, Devarie M, Xia X, Ingram DR, Dibra D, Somaiah N, Torres KE, Ravi V, Ludwig JA, Kleinerman ES, Li S. Satelli A, et al. Among authors: dibra d. Cancer Res. 2014 Mar 15;74(6):1645-50. doi: 10.1158/0008-5472.CAN-13-1739. Epub 2014 Jan 21. Cancer Res. 2014. PMID: 24448245 Free PMC article.

Cite

Share

6

Cite

Share

IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin.

Dibra D, Mitra A, Newman M, Xia X, Keenan C, Cutrera JJ, Mathis JM, Wang XJ, Myers J, Li S. Dibra D, et al. Oncotarget. 2016 Nov 22;7(47):77138-77151. doi: 10.18632/oncotarget.12581. Oncotarget. 2016. PMID: 27738312 Free PMC article.

Cite

Share

7

Cite

Share

WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells.

Dibra D, Cutrera J, Xia X, Li S. Dibra D, et al. PLoS One. 2011 Apr 29;6(4):e19072. doi: 10.1371/journal.pone.0019072. PLoS One. 2011. PMID: 21559505 Free PMC article.

Cite

Share

8

Cite

Share

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Yan J, Kong LY, Hu J, Gabrusiewicz K, Dibra D, Xia X, Heimberger AB, Li S. Yan J, et al. Among authors: dibra d. J Natl Cancer Inst. 2015 May 13;107(8):djv137. doi: 10.1093/jnci/djv137. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 25971300 Free PMC article.

Cite

Share

9

Cite

Share

Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice.

Dibra D, Xia X, Mitra A, Cutrera JJ, Lozano G, Li S. Dibra D, et al. Hepatology. 2016 Mar;63(3):1000-12. doi: 10.1002/hep.28379. Epub 2016 Jan 21. Hepatology. 2016. PMID: 26637970 Free PMC article.

Cite

Share

10

Cite

Share

Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury.

Dibra D, Cutrera J, Xia X, Kallakury B, Mishra L, Li S. Dibra D, et al. Hepatology. 2012 Apr;55(4):1204-14. doi: 10.1002/hep.24814. Epub 2012 Mar 1. Hepatology. 2012. PMID: 22105582 Free PMC article.

Cite

Share